Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-05-10 Purchase |
2022-05-10 7:58 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
9,700 | $1.7559 | $17,032 | 3,585,420 (Indirect) |
View |
2022-04-22 Purchase |
2022-04-29 6:27 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
7,100 | $1.98 | $14,058 | 3,584,220 (Indirect) |
View |
2022-04-22 Purchase |
2022-04-25 5:55 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
52,777 | $2.2252 | $117,438 | 3,583,220 (Indirect) |
View |
2022-04-07 Purchase(A) |
2022-04-15 06:15 am |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
10,136 | $4.7836 | $48,487 | 127,500 (Indirect) |
View |
2022-04-13 Purchase |
2022-04-14 6:13 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
20,041 | $2.4994 | $50,091 | 3,578,147 (Indirect) |
View |
2022-04-12 Purchase |
2022-04-13 6:33 pm |
HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner |
41,389 | $6.7531 | $279,502 | 157,732 (Indirect) |
View |
2022-04-11 Purchase |
2022-04-12 7:38 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
27,198 | $2.4578 | $66,846 | 3,573,106 (Indirect) |
View |
2022-04-07 Purchase |
2022-04-08 6:45 pm |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
10,136 | $4.7836 | $48,487 | 128 (Indirect) |
View |
2022-03-16 Purchase |
2022-03-17 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
2,235 | $2.2 | $4,917 | 6,085,841 (Indirect) |
View |
2022-01-28 Purchase |
2022-01-31 4:05 pm |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
24,031 | $4.9632 | $119,271 | 124,031 (Indirect) |
View |
2022-01-28 Purchase |
2022-01-31 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
500 | $2.2 | $1,100 | 6,068,606 (Indirect) |
View |
2022-01-28 Purchase |
2022-01-31 4:05 pm |
HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner |
6,343 | $6.8873 | $43,686 | 150,000 (Indirect) |
View |
2022-01-21 Purchase |
2022-01-24 6:18 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
52,363 | $2.1468 | $112,414 | 3,565,469 (Indirect) |
View |
2022-01-19 Purchase |
2022-01-21 4:00 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
45,000 | $2.2452 | $101,032 | 3,558,106 (Indirect) |
View |
2021-12-28 Purchase |
2021-12-29 7:36 pm |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
11,591 | $6.5998 | $76,498 | 120,000 (Indirect) |
View |
2021-12-29 Purchase |
2021-12-29 7:14 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
52,325 | $2.5105 | $131,362 | 3,553,106 (Indirect) |
View |
2021-12-27 Purchase |
2021-12-29 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
107,450 | $2.8669 | $308,052 | 3,533,106 (Indirect) |
View |
2021-12-23 Purchase |
2021-12-27 6:52 pm |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
38,000 | $6.534 | $248,293 | 110,000 (Indirect) |
View |
2021-12-20 Purchase |
2021-12-22 4:05 pm |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
703 | $6.49 | $4,562 | 2,496,209 (Indirect) |
View |
2021-12-16 Purchase |
2021-12-20 4:00 pm |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
10,353 | $6.4618 | $66,899 | 104,200 (Indirect) |
View |
2021-12-15 Purchase |
2021-12-16 4:01 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
21,964 | $2.4261 | $53,287 | 3,501,181 (Indirect) |
View |
2021-12-13 Purchase |
2021-12-15 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
57,204 | $2.561 | $146,498 | 3,499,217 (Indirect) |
View |
2021-12-03 Purchase |
2021-12-07 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
112,007 | $2.289 | $256,385 | 3,491,013 (Indirect) |
View |
2021-12-01 Purchase |
2021-12-03 5:14 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
60,500 | $2.3937 | $144,820 | 3,479,006 (Indirect) |
View |
2021-11-17 Purchase |
2021-11-19 4:10 pm |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
24,324 | $6.9797 | $169,774 | 102,647 (Indirect) |
View |
2021-11-17 Sale |
2021-11-19 4:09 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
25,000 | $4.6685 | $116,713 | 2,375,000 (Indirect) |
View |
2021-11-15 Sale |
2021-11-17 4:33 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
15,438 | $4.8502 | $74,877 | 85,000 (Indirect) |
View |
2021-11-05 Sale |
2021-11-09 4:46 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
220,362 | $6.2533 | $1,377,986 | 86,438 (Indirect) |
View |
2021-11-04 Purchase |
2021-11-08 2:30 pm |
Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner |
6,557 | $6.5 | $42,621 | 100,557 (Indirect) |
View |
2021-11-03 Sale |
2021-11-05 4:13 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
202,200 | $6.4911 | $1,312,501 | 97,500 (Indirect) |
View |
2021-10-08 Sale |
2021-10-13 07:57 am |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
165,100 | $5.0313 | $830,670 | 117,100 (Indirect) |
View |
2021-08-19 Purchase |
2021-08-23 5:59 pm |
HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner |
52,500 | $8.445 | $443,363 | 150,000 (Indirect) |
View |
2021-08-17 Purchase |
2021-08-19 7:10 pm |
HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner |
72,500 | $8.6165 | $624,697 | 147,500 (Indirect) |
View |
2021-08-04 Sale |
2021-08-06 9:53 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
604,500 | $5.8283 | $3,523,187 | 117,100 (Indirect) |
View |
2021-07-19 Purchase |
2021-07-22 09:19 am |
HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner |
20,000 | $7.3145 | $146,290 | 145,000 (Indirect) |
View |
2021-06-17 Purchase |
2021-06-22 11:44 am |
HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner |
74,584 | $8.3448 | $622,389 | 140,000 (Indirect) |
View |
2021-06-15 Sale(A) |
2021-06-21 06:05 am |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
105,000 | $8.07 | $847,350 | 141,600 (Indirect) |
View |
2021-06-15 Sale |
2021-06-17 4:39 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
105,000 | $8.07 | $847,350 | 141,600 (Indirect) |
View |
2021-05-25 Sale |
2021-05-27 7:34 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
242,300 | $8.5205 | $2,064,511 | 145,600 (Indirect) |
View |
2020-12-22 Purchase |
2020-12-28 09:53 am |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
496,277 | $8.06 | $3,999,993 | 5,766,877 (Indirect) |
View |